Regulation of adipocyte lipolysis

Nutrition Research Reviews

Volumn 27, Issue 1, 2014, Pages 63-93

  Frühbeck, Gema ^a,b   Méndez Giménez, Leire ^a,b   Fernández Formoso, José Antonio ^b   Fernández, Secundino ^a,b   Rodríguez, Amaia ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adipocyte TAG lipase; Adipokines; Catecholamines; Hormone sensitive lipase; Insulin; Lipid mobilisation; Perilipin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALPHA BETA HYDROLASE DOMAIN CONTAINING PROTEIN 5; AQUAPORIN 7; ATRIAL NATRIURETIC FACTOR; CAVEOLIN 1; CD36 ANTIGEN; COACTIVATOR COMPARATIVE GENE IDENTIFICATION 58; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; ENDOCANNABINOID; FAT DROPLET; FATTY ACID; FATTY ACID BINDING PROTEIN; GLYCEROL; GPIHBP1 PROTEIN; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INTERLEUKIN 15; INTERLEUKIN 6; LEPTIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOACYLGLYCEROL; NATRIURETIC FACTOR; PERILIPIN; RAB PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHOLESTEROL ESTERASE; PEPTIDE HORMONE; PERILIPIN 1; PHOSPHOPROTEIN; PROTEIN KINASE; TRIACYLGLYCEROL; ADENOSINE A1 RECEPTOR; ANGIOTENSIN II; APELIN; CATECHOLAMINE; CORTICOTROPIN; DIACYLGLYCEROL; GLUCAGON; HORMONE SENSITIVE LIPASE; HYDROCORTISONE; NITRIC OXIDE; PARATHYROID HORMONE; PIGMENT EPITHELIUM DERIVED FACTOR; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ARTICLE; AUTOPHAGY; CATECHOLAMINE NERVE CELL; GENE IDENTIFICATION; HORMONAL REGULATION; HUMAN; HYDROLYSIS; LIPID METABOLISM; LIPOLYSIS; LIPOPHAGOCYTOSIS; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ADIPOSE TISSUE; CYTOLOGY; METABOLISM; NEUROSECRETION; PHYSIOLOGY; ADIPOGENESIS; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; GENETIC VARIABILITY; LIPOGENESIS;

ADIPOCYTES; ADIPOSE TISSUE; CARRIER PROTEINS; CYCLIC AMP; HUMANS; LIPOLYSIS; NEUROSECRETORY SYSTEMS; PEPTIDE HORMONES; PHOSPHOPROTEINS; PROTEIN KINASES; STEROL ESTERASE; TRIGLYCERIDES;

EID: 84903885666     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S095442241400002X     Document Type: Article

References (436)

1. Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201-1210.
2. Arner P (2005) Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19, 471-482. (Pubitemid 41819214)
3. Duncan RE, Ahmadian M, Jaworski K, et al. (2007) Regulation of lipolysis in adipocytes. Annu Rev Nutr 27, 79-101. (Pubitemid 351373349)
4. Lafontan M & Langin D (2009) Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48, 275-297.
5. Girousse A & Langin D (2012) Adipocyte lipases and lipid droplet-Associated proteins: insight from transgenic mouse models. Int J Obes (Lond) 36, 581-594.
6. Zechner R, Zimmermann R, Eichmann TO, et al. (2012) Fat signals-lipases and lipolysis in lipid metabolism and signaling. Cell Metab 15, 279-291.
7. Young SG & Zechner R (2013) Biochemistry and pathophy-siology of intravascular and intracellular lipolysis. Genes Dev 27, 459-484.
8. Guilherme A, Virbasius JV, Puri V, et al. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9, 367-377. (Pubitemid 351574198)
9. Girousse A, Tavernier G, Valle C, et al. (2013) Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol 11, e1001485.
10. Virtue S & Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome-An allostatic perspective. Biochim Biophys Acta 1801, 338-349.
11. Unger RH, Clark GO, Scherer PE, et al. (2010) Lipid homeo-stasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801, 209-214.
12. Unger RH, Scherer PE & Holland WL (2013) Dichotomous roles of leptin and adiponectin as enforcers against lipo-toxicity during feast and famine. Mol Biol Cell 24, 3011-3015.
13. Gross DN, Miyoshi H, Hosaka T, et al. (2006) Dynamics of lipid droplet-Associated proteins during hormonally stimulated lipolysis in engineered adipocytes: stabilization and lipid droplet binding of adipocyte differentiation-related protein/adipophilin. Mol Endocrinol 20, 459-466. (Pubitemid 43152518)
14. Ducharme NA & Bickel PE (2008) Lipid droplets in lipogen-esis and lipolysis. Endocrinology 149, 942-949.
15. Greenberg AS, Coleman RA, Kraemer FB, et al. (2011) The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest 121, 2102-2110.
16. Hashimoto T, Segawa H, Okuno M, et al. (2012) Active involvement of micro-lipid droplets and lipid-droplet-Associated proteins in hormone-stimulated lipolysis in adipocytes. J Cell Sci 125, 6127-6136.
17. Walther TC & Farese RV Jr (2012) Lipid droplets and cellular lipid metabolism. Annu Rev Biochem 81, 687-714.
18. Langin D, Lucas S & Lafontan M (2000) Millennium fat-cell lipolysis reveals unsuspected novel tracks. Horm Metab Res 32, 443-452. (Pubitemid 32176071)
19. Frühbeck G & Gómez-Ambrosi J (2003) Control of body weight: a physiologic and transgenic perspective. Diabeto-logia 46, 143-172. (Pubitemid 36343879)
20. Bousquet-Melou A, Galitzky J, Lafontan M, et al. (1995) Control of lipolysis in intra-Abdominal fat cells of nonhuman primates: comparison with humans. J Lipid Res 36, 451-461.
21. Langin D, Portillo MP, Saulnier Blache JS, et al. (1991) Coexistence of three b-Adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol 199, 291-301.
22. Blaak EE (2000) Adrenergically stimulated fat utilization and ageing. Ann Med 32, 380-382.
23. Imbeault P, Prud'Homme D, Tremblay A, et al. (2000) Adipose tissue metabolism in young and middle-Aged men after control for total body fatness. J Clin Endocrinol Metab 85, 2455-2462. (Pubitemid 32269200)
24. Toth MJ & Tchernof A (2000) Lipid metabolism in the elderly. Eur J Clin Nutr 54, Suppl. 3, S121-S125. (Pubitemid 30447308)
25. Herrera E (2002) Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 19, 43-55. (Pubitemid 36106251)
26. Blaak E (2001) Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 4, 499-502. (Pubitemid 34755406)
27. Lange KH (2004) Fat metabolism in exercise-with special reference to training and growth hormone administration. Scand J Med Sci Sports 14, 74-99. (Pubitemid 38586589)
28. Mauriege P, Prud'Homme D, Marcotte M, et al. (1997) Regional differences in adipose tissue metabolism between sedentary and endurance-trained women. Am J Physiol 273, E497-E506. (Pubitemid 27418755)
29. Stich V, de Glisezinski I, Galitzky J, et al. (1999) Endurance training increases the b-Adrenergic lipolytic response in subcutaneous adipose tissue in obese subjects. Int J Obes Relat Metab Disord 23, 374-381. (Pubitemid 29182396)
30. De Glisezinski I, Crampes F, Harant I, et al. (1998) Endurance training changes in lipolytic responsiveness of obese adipose tissue. Am J Physiol 275, E951-E956. (Pubitemid 29025063)
31. De Glisezinski I, Marion-Latard F, Crampes F, et al. (2001) Lack of a2-Adrenergic antilipolytic effect during exercise in subcutaneous adipose tissue of trained men. J Appl Physiol 91, 1760-1765. (Pubitemid 32900369)
32. Westerterp-Plantenga MS, Lejeune MP & Kovacs EM (2005) Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 13, 1195-1204.
33. Murosaki S, Lee TR, Muroyama K, et al. (2007) A combination of caffeine, arginine, soy isoflavones, and l-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J Nutr 137, 2252-2257. (Pubitemid 47529586)
34. McCarty MF & Thomas CA (2003) PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 61, 535-542. (Pubitemid 37411898)
35. Shi H, Dirienzo D & Zemel MB (2001) Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-Agouti transgenic mice. FASEB J 15, 291-293.
36. Zemel MB, Thompson W, Milstead A, et al. (2004) Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 12, 582-590. (Pubitemid 41132500)
37. Xue B, Greenberg AG, Kraemer FB, et al. (2001) Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J 15, 2527-2529.
38. Major GC, Chaput JP, Ledoux M, et al. (2008) Recent developments in calcium-related obesity research. Obes Rev 9, 428-445.
39. Kang L & Nagy LE (2006) Chronic ethanol feeding suppresses b-Adrenergic receptor-stimulated lipolysis in adipocytes isolated from epididymal fat. Endocrinology 147, 4330-4338. (Pubitemid 44268384)
40. Arner P (2001) Genetic variance and lipolysis regulation: implications for obesity. Ann Med 33, 542-546. (Pubitemid 33052275)
41. Umekawa T, Yoshida T, Sakane N, et al. (1999) Trp64Arg mutation of b3-Adrenoceptor gene deteriorates lipolysis induced by b3-Adrenoceptor agonist in human omental adipocytes. Diabetes 48, 117-120. (Pubitemid 29019361)
42. Large V, Hellstrom L, Reynisdottir S, et al. (1997) Human b-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte b-2 adreno-ceptor function. J Clin Invest 100, 3005-3013. (Pubitemid 28022837)
43. Klannemark M, Orho M, Langin D, et al. (1998) The putative role of the hormone-sensitive lipase gene in the pathogenesis of type II diabetes mellitus and abdominal obesity. Diabetologia 41, 1516-1522. (Pubitemid 28551624)
44. Magre J, Laurell H, Fizames C, et al. (1998) Human hormone-sensitive lipase: genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM. Diabetes 47, 284-286. (Pubitemid 28079989)
45. Arner P (1999) Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord 23, Suppl. 1, 10-13. (Pubitemid 29101370)
46. Dodt C, Lonnroth P, Fehm HL, et al. (1999) Intraneural stimulation elicits an increase in subcutaneous interstitial glycerol levels in humans. J Physiol 521, 545-552. (Pubitemid 30003933)
47. Dodt C, Lonnroth P, Wellhoner JP, et al. (2003) Sympathetic control of white adipose tissue in lean and obese humans. Acta Physiol Scand 177, 351-357. (Pubitemid 36337638)
48. Brito MN, Brito NA, Baro DJ, et al. (2007) Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 148, 5339-5347. (Pubitemid 350012626)
49. Bartness TJ & Song CK (2007) Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue. J Lipid Res 48, 1655-1672. (Pubitemid 47311983)
50. Kreier F, Fliers E, Voshol PJ, et al. (2002) Selective parasym-pathetic innervation of subcutaneous and intra-Abdominal fat-functional implications. J Clin Invest 110, 1243-1250. (Pubitemid 35285750)
51. Bartness TJ (2002) Dual innervation of white adipose tissue: some evidence for parasympathetic nervous system involvement. J Clin Invest 110, 1235-1237. (Pubitemid 35285748)
52. Giordano A, Song CK, Bowers RR, et al. (2006) White adipose tissue lacks significant vagal innervation and immuno-histochemical evidence of parasympathetic innervation. Am J Physiol Regul Integr Comp Physiol 291, R1243-R1255.
53. Jocken JW & Blaak EE (2008) Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol Behav 94, 219-230. (Pubitemid 351615431)
54. De Matteis R, Arch JR, Petroni ML, et al. (2002) Immunohis-tochemical identification of the b3-Adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 26, 1442-1450. (Pubitemid 36005774)
55. Buemann B, Toubro S & Astrup A (2000) Effects of the two b3-Agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects. Int J Obes Relat Metab Disord 24, 1553-1560.
56. Redman LM, de Jonge L, Fang X, et al. (2007) Lack of an effect of a novel b3-Adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study. J Clin Endocrinol Metab 92, 527-531.
57. Gómez-Ambrosi J, Frühbeck G, Aguado M, et al. (2001) Divergent effects of an a2-Adrenergic antagonist on lipolysis and thermogenesis: interactions with a b3-Adrenergic agonist in rats. Int J Mol Med 8, 103-109.
58. Lafontan M & Berlan M (1995) Fat cell a2-Adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 16, 716-738. (Pubitemid 3020183)
59. Langin D (2006) Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53, 482-491. (Pubitemid 43767551)
60. Frühbeck G, Becerril S, Sáinz N, et al. (2009) BAT: a new target for human obesity? Trends Pharmacol Sci 30, 387-396.
61. Frühbeck G, Sesma P & Burrell MA (2009) PRDM16: the interconvertible adipo-myocyte switch. Trends Cell Biol 19, 141-146.
62. Lafontan M (2005) Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 45, 119-146. (Pubitemid 40261800)
63. Jaworski K, Sarkadi-Nagy E, Duncan RE, et al. (2007) Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol 293, G1-G4. (Pubitemid 47105157)
64. Møller N & Jørgensen JOL (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30, 152-177.
65. Yip RG & Goodman HM (1999) Growth hormone and dexa-methasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gia2 to lower density membrane fractions. Endocrinology 140, 1219-1227. (Pubitemid 29104224)
66. Gravholt CH, Schmitz O, Simonsen L, et al. (1999) Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. Am J Physiol 277, E848-E854.
67. Samra JS, Clark ML, Humphreys SM, et al. (1999) Suppression of the nocturnal rise in growth hormone reduces subsequent lipolysis in subcutaneous adipose tissue. Eur J Clin Invest 29, 1045-1052.
68. Sakharova AA, Horowitz JF, Surya S, et al. (2008) Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting. J Clin Endocrinol Metab 93, 2755-2759. (Pubitemid 352008547)
69. Nordstrom SM, Tran JL, Sos BC, et al. (2013) Disruption of JAK2 in adipocytes impairs lipolysis and improves fatty liver in mice with elevated GH. Mol Endocrinol 27, 1333-1342.
70. Djurhuus CB, Gravholt CH, Nielsen S, et al. (2002) Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol Endocrinol Metab 283, E172-E177. (Pubitemid 34686683)
71. Samra JS, Clark ML, Humphreys SM, et al. (1998) Effects of physiological hypercortisolemia on the regulation of lipo-lysis in subcutaneous adipose tissue. J Clin Endocrinol Metab 83, 626-631. (Pubitemid 28496549)
72. Ottosson M, Lonnroth P, Björntorp P, et al. (2000) Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J Clin Endocrinol Metab 85, 799-803. (Pubitemid 32279603)
73. Taniguchi A, Kataoka K, Kono T, et al. (1987) Parathyroid hormone-induced lipolysis in human adipose tissue. J Lipid Res 28, 490-494. (Pubitemid 17116183)
74. Xu XF, De Pergola G & Bjorntorp P (1991) Testosterone increases lipolysis and the number of b-Adrenoceptors in male rat adipocytes. Endocrinology 128, 379-382.
75. Dicker A, Ryden M, Naslund E, et al. (2004) Effect of testosterone on lipolysis in human pre-Adipocytes from different fat depots. Diabetologia 47, 420-428. (Pubitemid 38491238)
76. Arner P (2005) Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome. Biochimie 87, 39-43. (Pubitemid 40298764)
77. Zang H, Ryden M, Wahlen K, et al. (2007) Effects of testosterone and estrogen treatment on lipolysis signaling pathways in subcutaneous adipose tissue of postmeno-pausal women. Fertil Steril 88, 100-106. (Pubitemid 47001373)
78. Fan W, Yanase T, Nomura M, et al. (2005) Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54, 1000-1008. (Pubitemid 40450323)
79. Blouin K, Nadeau M, Perreault M, et al. (2010) Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin Endocrinol (Oxf) 72, 176-188.
80. Bertin E, Arner P, Bolinder J, et al. (2001) Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipo-lysis in human subcutaneous adipose tissue and skeletal muscle in vivo. J Clin Endocrinol Metab 86, 1229-1234. (Pubitemid 32323009)
81. Gravholt CH, Moller N, Jensen MD, et al. (2001) Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis. J Clin Endocrinol Metab 86, 2085-2089. (Pubitemid 32472924)
82. Sancho V, Trigo MV, Martin-Duce A, et al. (2006) Effect of GLP-1 on d-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects. Int J Mol Med 17, 1133-1137.
83. Vendrell J, El Bekay R, Peral B, et al. (2011) Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology 152, 4072-4079.
84. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, et al. (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280, E827-E847. (Pubitemid 32553225)
85. Frühbeck G & Gómez Ambrosi J (2001) Rationale for the existence of additional adipostatic hormones. FASEB J 15, 1996-2006.
86. Trayhurn P (2007) Adipocyte biology. Obes Rev 8, Suppl. 1, 41-44.
87. Sun K, Kusminski CM & Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121, 2094-2101.
88. Fortuño A, Rodríguez A, Gómez-Ambrosi J, et al. (2003) Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem 59, 51-60. (Pubitemid 36889354)
89. Frühbeck G (2006) Hunting for new pieces to the complex puzzle of obesity. Proc Nutr Soc 65, 329-347.
90. Ahima RS & Lazar MA (2008) Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22, 1023-1031. (Pubitemid 351629604)
91. Gómez-Ambrosi J, Rodríguez A, Catalán V, et al. (2008) The bone-Adipose axis in obesity and weight loss. Obes Surg 18, 1134-1143.
92. Liu Y, Song CY, Wu SS, et al. (2013) Novel adipokines and bone metabolism. Int J Endocrinol 2013, 895045.
93. Trayhurn P (2013) Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 93, 1-21.
94. Hefetz-Sela S & Scherer PE (2013) Adipocytes: impact on tumor growth and potential sites for therapeutic intervention. Pharmacol Ther 138, 197-210.
95. Gómez-Ambrosi J & Frühbeck G (2001) Do resistin and resistin-like molecules also link obesity to inflammatory diseases? Ann Intern Med 135, 306-307.
96. Gómez-Ambrosi J, Salvador J, Páramo JA, et al. (2002) Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 35, 315-320. (Pubitemid 34804903)
97. Fortuño A, Rodríguez A, Gómez-Ambrosi J, et al. (2002) Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology 143, 3555-3560. (Pubitemid 34925731)
98. Rodríguez A, Catalán V, Becerril S, et al. (2008) Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats. Life Sci 83, 540-549.
99. Poulain-Godefroy O, Lecoeur C, Pattou F, et al. (2008) Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol Regul Integr Comp Physiol 295, R1-R7.
100. Muruzábal FJ, Frühbeck G, Gómez-Ambrosi J, et al. (2002) Immunocytochemical detection of leptin in non-mammalian vertebrate stomach. Gen Comp Endocrinol 128, 149-152. (Pubitemid 35257842)
101. Martín M, Burrell MA, Gómez-Ambrosi J, et al. (2012) Short-And long-term changes in gastric morphology and histopathology following sleeve gastrectomy in diet-induced obese rats. Obes Surg 22, 634-640.
102. Seeley RJ & Tschöp MH (2011) Uroguanylin: how the gut got another satiety hormone. J Clin Invest 121, 3384-3386.
103. Frühbeck G (2012) Gastrointestinal hormones: uroguanylin-A new gut-derived weapon against obesity? Nat Rev Endocrinol 8, 5-6.
104. Campo A, Frühbeck G, Zulueta JJ, et al. (2007) Hyper-leptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J 30, 223-231. (Pubitemid 47194174)
105. Fernández-Real JM, Valdés S, Manco M, et al. (2010) Surfactant protein D, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care 33, 847-853.
106. Weng M, Raher MJ, Leyton P, et al. (2011) Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension. Am J Respir Cell Mol Biol 45, 340-347.
107. Sáinz N, Rodríguez A, Catalán V, et al. (2010) Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice. Mediators Inflamm 2010, 784343.
108. Sáinz N, Rodríguez A, Catalán V, et al. (2012) Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice. PLOS ONE 7, e29389.
109. Taube A, Lambernd S, van Echten-Deckert G, et al. (2012) Adipokines promote lipotoxicity in human skeletal muscle cells. Arch Physiol Biochem 118, 92-101.
110. Sáinz N, Rodríguez A, Catalán V, et al. (2009) Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1a in ob/ob mice. PLoS ONE 4, e6808.
111. Gannagé-Yared MH, Yaghi C, Habre B, et al. (2008) Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. Eur J Endocrinol 158, 353-359. (Pubitemid 351405000)
112. Trayhurn P, Drevon CA & Eckel J (2011) Secreted proteins from adipose tissue and skeletal muscle-Adipokines, myokines and adipose/muscle cross-talk. Arch Physiol Biochem 117, 47-56.
113. Berg AH & Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96, 939-949. (Pubitemid 40712793)
114. Qatanani M & Lazar MA (2007) Mechanisms of obesity-Associated insulin resistance: many choices on the menu. Genes Dev 21, 1443-1455. (Pubitemid 46955717)
115. Arner P, Bernard S, Salehpour M, et al. (2011) Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 478, 110-113.
116. Arner E, Rydén M & Arner P (2010) Tumor necrosisfactoraand regulation of adipose tissue. N Engl J Med 362, 1151-1153.
117. Langin D & Arner P (2006) Importance of TNFa and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol Metab 17, 314-320. (Pubitemid 44419491)
118. Laurencikiene J, van Harmelen V, Arvidsson Nordström E, et al. (2007) NF-kB is important for TNF-A-induced lipolysis in human adipocytes. J Lipid Res 48, 1069-1077. (Pubitemid 46708674)
119. Cawthorn WP & Sethi JK (2008) TNF-A and adipocyte biology. FEBS Lett 582, 117-131.
120. Ryden M & Arner P (2007) Tumour necrosis factor-A in human adipose tissue-from signalling mechanisms to clinical implications. J Intern Med 262, 431-438. (Pubitemid 47404374)
121. González-Yanes C & Sánchez-Margalet V (2006) Signalling mechanisms regulating lipolysis. Cell Signal 18, 401-408.
122. Botion LM, Brasier AR, Tian B, et al. (2001) Inhibition of proteasome activity blocks the ability of TNFa to down-regulate Gi proteins and stimulate lipolysis. Endocrinology 142, 5069-5075. (Pubitemid 33131932)
123. Xu H & Hotamisligil GS (2001) Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation. FEBS Lett 506, 97-102. (Pubitemid 32925207)
124. Xu H, Hirosumi J, Uysal KT, et al. (2002) Exclusive action of transmembrane TNF a in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 143, 1502-1511. (Pubitemid 34274381)
125. Zhang HH, Halbleib M, Ahmad F, et al. (2002) Tumor necrosis factor-A stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51, 2929-2935.
126. Souza SC, Palmer HJ, Kang YH, et al. (2003) TNF-A induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J Cell Biochem 89, 1077-1086. (Pubitemid 36959377)
127. Jager J, Gremeaux T, Gonzalez T, et al. (2010) Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1b and tumor necrosis factor-A effects on extracellular signal-regulated kinase activation and lipolysis. Diabetes 59, 61-70.
128. van Hall G, Steensberg A, Sacchetti M, et al. (2003) Inter-leukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88, 3005-3010. (Pubitemid 36877463)
129. Yang Y, Ju D, Zhang M, et al. (2008) Interleukin-6 stimulates lipolysis in porcine adipocytes. Endocrine 33, 261-269.
130. Jensen MD (2003) Cytokine regulation of lipolysis in humans? J Clin Endocrinol Metab 88, 3003-3004.
131. Morisset AS, Huot C, Legare D, et al. (2008) Circulating IL-6 concentrations and abdominal adipocyte isoproterenol-stimulated lipolysis in women. Obesity (Silver Spring) 16, 1487-1492. (Pubitemid 351915113)
132. Holmes AG, Watt MJ & Febbraio MA (2004) Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans. J Appl Physiol 97, 689-696. (Pubitemid 38963143)
133. Hiscock N, Fischer CP, Sacchetti M, et al. (2005) Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans. Am J Physiol Endocrinol Metab 289, E2-E7. (Pubitemid 40874927)
134. Carbo N, Lopez-Soriano J, Costelli P, et al. (2001) Interleu-kin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta 1526, 17-24. (Pubitemid 32245767)
135. Ajuwon KM & Spurlock ME (2004) Direct regulation of lipo-lysis by interleukin-15 in primary pig adipocytes. Am J Physiol Regul Integr Comp Physiol 287, R608-R611. (Pubitemid 39095936)
136. Quinn LS, Strait-Bodey L, Anderson BG, et al. (2005) Inter-leukin-15 stimulates adiponectin secretion by 3T3-L1 adipo-cytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int 29, 449-457. (Pubitemid 41073643)
137. Frühbeck G, Jebb SA & Prentice AM (1998) Leptin: physiology and pathophysiology. Clin Physiol 18, 399-419. (Pubitemid 28451466)
138. Frühbeck G (2002) Peripheral actions of leptin and its involvement in disease. Nutr Rev 60, S47-S55.
139. Frühbeck G (2001) A heliocentric view of leptin. Proc Nutr Soc 60, 301-318.
140. Frühbeck G, Aguado M & Martínez JA (1997) In vitro lipo-lytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 240, 590-594. (Pubitemid 28271762)
141. Frühbeck G, Aguado M, Gómez-Ambrosi J, et al. (1998) Lipolytic effect of in vivo leptin administration on adipo-cytes of lean and ob/ob mice, but not db/db mice. Biochem Biophys Res Commun 250, 99-102. (Pubitemid 28448630)
142. Wang MY, Lee Y & Unger RH (1999) Novel form of lipolysis induced by leptin. J Biol Chem 274, 17541-17544.
143. Frühbeck G, Gómez Ambrosi J & Salvador J (2001) Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J 15, 333-340. (Pubitemid 32141425)
144. Honnor RC, Dhillon GS & Londos C (1985) cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J Biol Chem 260, 15122-15129. (Pubitemid 16148001)
145. Honnor RC, Dhillon GS & Londos C (1985) cAMP-dependent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators. J Biol Chem 260, 15130-15138. (Pubitemid 16148002)
146. Rice AM, Fain JN & Rivkees SA (2000) A1 adenosine receptor activation increases adipocyte leptin secretion. Endocrinology 141, 1442-1445. (Pubitemid 32269112)
147. Greenberg AS, Taylor SI & Londos C (1987) Presence of a functional inhibitory GTP-binding regulatory component, Gi, linked to adenylate cyclase in adipocytes of ob/ob mice. J Biol Chem 262, 4564-4568. (Pubitemid 17102819)
148. Vannucci SJ, Klim CM, Martin LF, et al. (1989) A1-Adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats. Am J Physiol 257, E871-E878.
149. Martin LF, Klim CM & Vannucci SJ (1990) Alterations in adipocyte adenylate cyclase activity in morbidly obese and formerly morbidly obese humans. Surgery 108, 228-234, ; discussion 234-225.
150. Wang MY, Orci L, Ravazzola M, et al. (2005) Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc Natl Acad Sci U S A 102, 18011-18016. (Pubitemid 41798493)
151. Gómez-Ambrosi J, Frühbeck G & Martínez JA (1999) Leptin, but not a b3-Adrenergic agonist, upregulates muscle uncoupling protein-3 messenger RNA expression: short-term thermogenic interactions. Cell Mol Life Sci 55, 992-997. (Pubitemid 29304451)
152. Frühbeck G & Salvador J (2000) Relations between leptin and the regulation of glucose metabolism. Diabetologia 43, 3-12. (Pubitemid 30129297)
153. Elinson N, Amichay D & Birk RZ (2006) Leptin directly regulates exocrine pancreas lipase and two related proteins in the rat. Br J Nutr 96, 691-696. (Pubitemid 46470193)
154. Morioka T, Asilmaz E, Hu J, et al. (2007) Disruption of leptin receptor expression in the pancreas directly affects b cell growth and function in mice. J Clin Invest 117, 2860-2868. (Pubitemid 47529616)
155. Ren J, Dong F, Cai G-J, et al. (2010) Interaction between age and obesity on cardiomyocyte contractile function: role of leptin and stress signaling. PLoS ONE 5, e10085.
156. Becerril S, Gómez-Ambrosi J, Martin M, et al. (2013) Role of PRDM16 in the activation of brown fat programming. Relevance to the development of obesity. Histol Histopathol 28, 1411-1425.
157. Huynh FK, Neumann UH, Wang Y, et al. (2013) A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice. Hepatology 57, 543-554.
158. Shapiro L & Scherer PE (1998) The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8, 335-338. (Pubitemid 28159119)
159. Bullo M, Salas-Salvado J & Garcia-Lorda P (2005) Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obes Surg 15, 382-386. (Pubitemid 40463607)
160. Lavoie F, Frisch F, Brassard P, et al. (2009) Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. J Clin Endocrinol Metab 94, 998-1004.
161. Wedellova Z, Dietrich J, Siklova-Vitkova M, et al. (2011) Adiponectin
162. Qiao L, Kinney B, Schaack J, et al. (2011) Adiponectin inhibits lipolysis in mouse adipocytes. Diabetes 60, 1519-1527.
163. Kovacova Z, Tencerova M, Roussel B, et al. (2012) The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue. Int J Obes 36, 1360-1365.
164. Wedellova Z, Kovacova Z, Tencerova M, et al. (2013) The impact of full-length, trimeric and globular adiponectin on lipolysis in subcutaneous and visceral adipocytes of obese and non-obese women. PLOS ONE 8, e66783.
165. Gaudiot N, Jaubert AM, Charbonnier E, et al. (1998) Modulation of white adipose tissue lipolysis by nitric oxide. J Biol Chem 273, 13475-13481. (Pubitemid 28268387)
166. Andersson K, Gaudiot N, Ribiere C, et al. (1999) A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol 126, 1639-1645. (Pubitemid 29182349)
167. Elizalde M, Ryden M, van Harmelen V, et al. (2000) Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 41, 1244-1251. (Pubitemid 30666890)
168. Engeli S, Janke J, Gorzelniak K, et al. (2004) Regulation of the nitric oxide system in human adipose tissue. J Lipid Res 45, 1640-1648. (Pubitemid 39296203)
169. Penfornis P & Marette A (2005) Inducible nitric oxide synthase modulates lipolysis in adipocytes. J Lipid Res 46, 135-142. (Pubitemid 40066679)
170. Engeli S, Boschmann M, Adams F, et al. (2007) Dissociation between adipose nitric oxide synthase expression and tissue metabolism. J Clin Endocrinol Metab 92, 2706-2711. (Pubitemid 47037379)
171. Frühbeck G (1999) Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48, 903-908. (Pubitemid 29153093)
172. Frühbeck G (2006) Intracellular signalling pathways activated by leptin. Biochem J 393, 7-20. (Pubitemid 43049298)
173. Frühbeck G & Gómez-Ambrosi J (2001) Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cell Signal 13, 827-833. (Pubitemid 32913691)
174. Becerril S, Rodríguez A, Catalán V, et al. (2010) Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function. PLoS ONE 5, e10962.
175. Becerril S, Rodríguez A, Catalán V, et al. (2012) Transcrip-tional analysis of brown adipose tissue in leptin-deficient mice lacking inducible nitric oxide synthase: evidence of the role of Med1 in energy balance. Physiol Genomics 44, 678-688.
176. Mehebik N, Jaubert AM, Sabourault D, et al. (2005) Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation. Am J Physiol Cell Physiol 289, C379-C387. (Pubitemid 41008884)
177. Lafontan M, Moro C, Berlan M, et al. (2008) Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 19, 130-137. (Pubitemid 351608304)
178. Sengenes C, Berlan M, De Glisezinski I, et al. (2000) Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14, 1345-1351. (Pubitemid 30439743)
179. Galitzky J, Sengenes C, Thalamas C, et al. (2001) The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 42, 536-544. (Pubitemid 32366996)
180. Sengenes C, Bouloumie A, Hauner H, et al. (2003) Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278, 48617-48626. (Pubitemid 41079500)
181. Moro C, Crampes F, Sengenes C, et al. (2004) Atrial natriure-tic peptide contributes to physiological control of lipid mobilization in humans. FASEB J 18, 908-910.
182. Moro C, Galitzky J, Sengenes C, et al. (2004) Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells. J Pharmacol Exp Ther 308, 984-992. (Pubitemid 38263974)
183. Moro C, Pillard F, de Glisezinski I, et al. (2008) Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men. Am J Physiol Endocrinol Metab 295, E505-E513.
184. Moro C, Pasarica M, Elkind-Hirsch K, et al. (2009) Aerobic exercise training improves atrial natriuretic peptide and catechol-Amine-mediated lipolysis in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 94, 2579-2586.
185. Birkenfeld AL, Budziarek P, Boschmann M, et al. (2008) Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 57, 3199-3204.
186. Moro C & Lafontan M (2013) Natriuretic peptides and cGMP signaling control of energy homeostasis. Am J Physiol Heart Circ Physiol 304, H358-H368.
187. Horvath TL (2003) Endocannabinoids and the regulation of body fat: the smoke is clearing. J Clin Invest 112, 323-326. (Pubitemid 38063759)
188. Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7, 438-455. (Pubitemid 351649182)
189. Moreno-Navarrete JM, Catalán V, Whyte L, et al. (2012) The l-A-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. Diabetes 61, 281-291.
190. Cota D, Marsicano G, Tschop M, et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112, 423-431. (Pubitemid 38063771)
191. Jbilo O, Ravinet-Trillou C, Arnone M, et al. (2005) The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 19, 1567-1569. (Pubitemid 41279033)
192. Engeli S, Bohnke J, Feldpausch M, et al. (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54, 2838-2843. (Pubitemid 41401077)
193. Matias I, Gonthier MP, Orlando P, et al. (2006) Regulation, function, and dysregulation of endocannabinoids in models of adipose and b-pancreatic cells and in obesity and hyper-glycemia. J Clin Endocrinol Metab 91, 3171-3180. (Pubitemid 44271774)
194. Guzman M, Lo Verme J, Fu J, et al. (2004) Oleoylethanola-mide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-Activated receptor a (PPAR-A). J Biol Chem 279, 27849-27854. (Pubitemid 38900052)
195. Martinez de Ubago M, Garcia-Oya I & Perez-Perez A (2009) Oleoylethanolamide, a natural ligand for PPAR-A, inhibits insulin receptor signalling in HTC rat hepatoma cells. Biochim Biophys Acta 1791, 740-745.
196. Muccioli G, Pons N, Ghe C, et al. (2004) Ghrelin and des-Acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secreta-gogue receptor. Eur J Pharmacol 498, 27-35. (Pubitemid 39208057)
197. Baragli A, Ghe C, Arnoletti E, et al. (2011) Acylated and unacylated ghrelin attenuate isoproterenol-induced lipoly-sis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase g and phosphodiesterase 3B. Biochim Biophys Acta 1811, 386-396.
198. Vestergaard ET, Gormsen LC, Jessen N, et al. (2008) Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 57, 3205-3210.
199. Rodríguez A, Gómez-Ambrosi J, Catalán V, et al. (2009) Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes 33, 541-552.
200. Rodríguez A, Gómez-Ambrosi J, Catalan V, et al. (2012) The ghrelin O-Acyltransferase-ghrelin system reduces TNF-A-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia 55, 3038-3050.
201. Carlson LA & Oro L (1962) The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis. Acta Med Scand 172, 641-645.
202. Carlson LA & Hanngren A (1964) Initial distribution in mice of 3H-labeled nicotinic acid studied with autoradiography. Life Sci 3, 867-871.
203. Karpe F & Frayn KN (2004) The nicotinic acid receptor-A new mechanism for an old drug. Lancet 363, 1892-1894. (Pubitemid 38748647)
204. Oh YT, Oh KS, Choi YM, et al. (2011) Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue. Am J Physiol Endocrinol Metab 300, E1012-E1021.
205. Tisdale MJ (2009) Zinc-A2-glycoprotein in cachexia and obesity. Curr Opin Support Palliat Care 3, 288-293.
206. Bing C, Mracek T, Gao D, et al. (2010) Zinc-A2-glycoprotein: an adipokine modulator of body fat mass? IntJ Obes (Lond) 34, 1559-1565.
207. Cabassi A & Tedeschi S (2013) Zinc-A2-glycoprotein as a marker of fat catabolism in humans. Curr Opin Clin Nutr Metab Care 16, 267-271.
208. Bing C, Bao Y, Jenkins J, et al. (2004) Zinc-A2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 101, 2500-2505. (Pubitemid 38269340)
209. Wargent ET, O'Dowd JF, Zaibi MS, et al. (2013) Contrasts between the effects of zinc-A2-glycoprotein, a putative b3/2-Adrenoceptor agonist and the b3/2-Adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice. J Endocrinol 216, 157-168.
210. Eckardt K, Schober A, Platzbecker B, et al. (2011) The adipokine zinc-A2-glycoprotein activates AMP kinase in human primary skeletal muscle cells. Arch Physiol Biochem 117, 88-93.
211. Sarzani R, Salvi F, Dessi-Fulgheri P, et al. (2008) Renin-Angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 26, 831-843. (Pubitemid 351540757)
212. Goossens GH, Blaak EE, Saris WH, et al. (2004) Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects. J Clin Endocrinol Metab 89, 2690-2696. (Pubitemid 38766351)
213. Frühbeck G (2004) The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2, 197-208. (Pubitemid 38864704)
214. Juan CC, Chang CL, Lai YH, et al. (2005) Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 288, E1146-E1152.
215. Juan CC, Chang LW, Huang SW, et al. (2006) Effect of endothelin-1 on lipolysis in rat adipocytes. Obesity (Silver Spring) 14, 398-404.
216. van Harmelen V, Eriksson A, Astrom G, et al. (2008) Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis. Diabetes 57, 378-386.
217. Eriksson AK, van Harmelen V, Stenson BM, et al. (2009) Endothelin-1 stimulates human adipocyte lipolysis through the ET A receptor. IntJ Obes (Lond) 33, 67-74.
218. Shichiri M, Fukai N, Ozawa N, et al. (2003) Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells. Regul Pept 112, 167-173. (Pubitemid 36351614)
219. Fukai N, Yoshimoto T, Sugiyama T, et al. (2005) Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues. Am J Physiol Endocrinol Metab 288, E56-E62. (Pubitemid 40023790)
220. Harmancey R, Senard JM, Pathak A, et al. (2005) The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated b-Adrenergic agonist oxidation. FASEB J 19, 1045-1047. (Pubitemid 40827746)
221. Iemura-Inaba C, Nishikimi T, Akimoto K, et al. (2008) Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes. Am J Physiol Regul Integr Comp Physiol 295, R1376-R1384.
222. Boucher J, Masri B, Daviaud D, et al. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146, 1764-1771. (Pubitemid 40396885)
223. Attane C, Daviaud D, Dray C, et al. (2011) Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. J Mol Endocrinol 46, 21-28.
224. Yue P, Jin H, Xu S, et al. (2011) Apelin decreases lipolysis via Gq, Gi, and AMPK-dependent mechanisms. Endocrinology 152, 59-68.
225. Than A, Cheng Y, Foh LC, et al. (2012) Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol 362, 227-241.
226. Crowe S, Wu LE, Economou C, et al. (2009) Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab 10, 40-47.
227. Sabater M, Moreno-Navarrete JM, Ortega FJ, et al. (2010) Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab 95, 4720-4728.
228. Borg ML, Andrews ZB, Duh EJ, et al. (2011) Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 60, 1458-1466.
229. Yamagishi S, Amano S, Inagaki Y, et al. (2003) Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Microvasc Res 65, 186-190. (Pubitemid 36438684)
230. Wang M, Wang JJ, Li J, et al. (2009) Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes. Am J Physiol Endocrinol Metab 297, E1378-E1387.
231. Moreno-Navarrete JM, Touskova V, Sabater M, et al. (2013) Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance. Int J Obes (Lond) 37, 1230-1237.
232. Gómez-Ambrosi J, Salvador J, Rotellar F, et al. (2006) Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg 16, 262-269.
233. Catalán V, Gómez-Ambrosi J, Rotellar F, et al. (2007) The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-Associated type 2 diabetes mellitus. Clin Endocrinol 66, 598-601. (Pubitemid 46434943)
234. Catalán V, Gómez-Ambrosi J, Ramírez B, et al. (2007) Pro-inflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 17, 1464-1474.
235. Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. (2009) Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and-9 activity in humans. J Mol Med 87, 803-813.
236. Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. (2011) Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. J Nutr Biochem 22, 634-641.
237. Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. (2011) Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity. Nutr Metab Cardiovasc Dis 21, 245-253.
238. Moreno-Navarrete JM, Catalán V, Ortega F, et al. (2010) Circulating omentin concentration increases after weight loss. Nutr Metab 7, 27.
239. Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. (2012) Increased tenascin C and toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. J Clin Endocrinol Metab 97, E1880-E1889.
240. Catalán V, Gomez-Ambrosi J, Rodríguez A, et al. (2013) Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-A stimulates mRNA levels of chemerin in visceral adipocytes from obese patients. Surg Obes Relat Dis 9, 306-314.
241. Gómez-Ambrosi J, Rodríguez A, Catalán V, et al. (2008) Serum retinol-binding protein 4 is not increased in obesity or obesity-Associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clin Endocrinol 69, 208-215. (Pubitemid 352009009)
242. Ding C, Gao D, Wilding J, et al. (2012) Vitamin D signalling in adipose tissue. Br J Nutr 108, 1915-1923.
243. Possenti R, Muccioli G, Petrocchi P, et al. (2012) Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21. Biochem J 441, 511-522.
244. Gómez-Ambrosi J, Catalán V, Ramírez B, et al. (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92, 3719-3727. (Pubitemid 47435361)
245. Fernández-Real JM, Izquierdo M, Ortega F, et al. (2009) The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 94, 237-245.
246. Bays HE, González-Campoy JM, Bray GA, et al. (2008) Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 6, 343-368.
247. Wood IS & Trayhurn P (2006) Adipokines and the signaling role of adipose tissue in inflammation and obesity. Future Lipidol 1, 81-89.
248. Haemmerle G, Lass A, Zimmermann R, et al. (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734-737.
249. Reynisdottir S, Dauzats M, Thorne A, et al. (1997) Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. J Clin Endocrinol Metab 82, 4162-4166. (Pubitemid 27525532)
250. Osuga J-I, Ishibashi S, Oka T, et al. (2000) Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci U S A 97, 787-792. (Pubitemid 30070388)
251. Fredrikson G, Tornqvist H & Belfrage P (1986) Hormonesensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylgly-cerol. Biochim Biophys Acta 876, 288-293. (Pubitemid 16014863)
252. Osuga J, Ishibashi S, Oka T, et al. (2000) Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci U S A 97, 787-792. (Pubitemid 30070388)
253. Shi Y & Burn P (2004) Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov 3, 695-710. (Pubitemid 39173510)
254. Granneman JG & Moore HP (2008) Location, location: protein trafficking and lipolysis in adipocytes. Trends Endocrinol Metab 19, 3-9.
255. Bezaire V & Langin D (2009) Regulation of adipose tissue lipolysis revisited. Proc Nutr Soc 68, 350-360.
256. Zimmermann R, Strauss JG, Haemmerle G, et al. (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306, 1383-1386. (Pubitemid 39532517)
257. Zechner R, Kienesberger PC, Haemmerle G, et al. (2009) Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 50, 3-21.
258. Schweiger M, Schreiber R, Haemmerle G, et al. (2006) Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281, 40236-40241. (Pubitemid 46041828)
259. Thompson BR, Lobo S & Bernlohr DA (2010) Fatty acid flux in adipocytes: the in's and out's of fat cell lipid trafficking. Mol Cell Endocrinol 318, 24-33.
260. Schweiger M, Schoiswohl G, Lass A, et al. (2008) The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding. J Biol Chem 283, 17211-17220.
261. Lass A, Zimmermann R, Oberer M, et al. (2011) Lipolysis-A highly regulated multi-enzyme complex mediates the cata-bolism of cellular fat stores. Prog Lipid Res 50, 14-27.
262. Chakrabarti P, Kim JY, Singh M, et al. (2013) Insulin inhibits lipolysis in adipocytes via the evolutionary conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol 33, 3659-3666.
263. Haemmerle G, Moustafa T, Woelkart G, et al. (2011) ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-A and PGC-1. Nat Med 17, 1076-1085.
264. Chakrabarti P & Kandror KV (2009) FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J Biol Chem 284, 13296-13300.
265. Chakrabarti P, English T, Shi J, et al. (2010) Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipo-genesis, and promotes fat storage. Diabetes 59, 775-781.
266. Chakrabarti P, English T, Karki S, et al. (2011) SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J Lipid Res 52, 1693-1701.
267. Yin W, Mu J & Birnbaum MJ (2003) Role of AMP-Activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J Biol Chem 278, 43074-43080. (Pubitemid 37345923)
268. Daval M, Diot-Dupuy F, Bazin R, et al. (2005) Anti-lipolytic action of AMP-Activated protein kinase in rodent adipo-cytes. J Biol Chem 280, 25250-25257. (Pubitemid 40934619)
269. Gauthier MS, Miyoshi H, Souza SC, et al. (2008) AMP-Activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem 283, 16514-16524.
270. Gaidhu MP, Fediuc S, Anthony NM, et al. (2009) Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J Lipid Res 50, 704-715.
271. Gaidhu MP, Bikopoulos G & Ceddia RB (2012) Chronic AICAR-induced AMP-kinase activation regulates adipocyte lipolysis in a time-dependent and fat depot-specific manner in rats. Am J Physiol Cell Physiol 303, C1192-C1197.
272. Yang X, Lu X, Lombès M, et al. (2010) The G0/G1 switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 11, 194-205.
273. Schweiger M, Paar M, Eder C, et al. (2012) G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipase. J Lipid Res 53, 2307-2317.
274. Mayer N, Schweiger M, Romauch M, et al. (2013) Development of small-molecule inhibitors targeting adipose triglyceride lipase. Nat Chem Biol 9, 785-787.
275. Okazaki H, Osuga J, Tamura Y, et al. (2002) Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases. Diabetes 51, 3368-3375. (Pubitemid 35403438)
276. Haemmerle G, Zimmermann R, Strauss JG, et al. (2002) Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. J Biol Chem 277, 12946-12952. (Pubitemid 34952662)
277. Holm C (2003) Molecular mechanisms regulating hormonesensitive lipase and lipolysis. Biochem Soc Trans 31, 1120-1124. (Pubitemid 38030921)
278. Peyot ML, Nolan CJ, Soni K, et al. (2004) Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1. Diabetes 53, 1733-1742. (Pubitemid 38857031)
279. Tansey JT, Sztalryd C, Gruia-Gray J, et al. (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98, 6494-6499. (Pubitemid 32488265)
280. Tansey JT, Sztalryd C, Hlavin EM, et al. (2004) The central role of perilipin A in lipid metabolism and adipocyte lipo-lysis. IUBMB Life 56, 379-385. (Pubitemid 39564301)
281. Sztalryd C, Xu G, Dorward H, et al. (2003) Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol 161, 1093-1103. (Pubitemid 36870171)
282. Belfrage P, Fredrikson G, Olsson H, et al. (1984) Regulation of adipose tissue lipolysis through reversible phosphoryl-Ation of hormone-sensitive lipase. Adv Cyclic Nucleotide Protein Phosphorylation Res 17, 351-359.
283. Ray H, Beylot M, Arner P, et al. (2003) The presence of a cat-Alytically inactive form of hormone-sensitive lipase is associated with decreased lipolysis in abdominal subcutaneous adipose tissue of obese subjects. Diabetes 52, 1417-1422. (Pubitemid 36666196)
284. Greenberg AS, Shen WJ, Muliro K, et al. (2001) Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem 276, 45456-45461.
285. Kralisch S, Klein J, Lossner U, et al. (2005) Isoproterenol, TNFa, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol 240, 43-49. (Pubitemid 41133370)
286. Kershaw EE, Hamm JK, Verhagen LA, et al. (2006) Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 55, 148-157. (Pubitemid 43343310)
287. Scherer T, O'Hare J, Diggs-Andrews K, et al. (2011) Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 13, 183-194.
288. Taschler U, Radner FP, Heier C, et al. (2011) Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J Biol Chem 286, 17467-17477.
289. Soni KG, Lehner R, Metalnikov P, et al. (2004) Carboxyles-terase 3 (EC 3.1.1.1) is a major adipocyte lipase. J Biol Chem 279, 40683-40689. (Pubitemid 39287663)
290. Wei E, Ben Ali Y, Lyon J, et al. (2010) Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab 11, 183-193.
291. Kienesberger PC, Oberer M, Lass A, et al. (2009) Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions. J Lipid Res 50, S63-S68.
292. Polson DA & Thompson MP (2003) Adiponutrin mRNA expression in white adipose tissue is rapidly induced by meal-feeding a high-sucrose diet. Biochem Biophys Res Commun 301, 261-266. (Pubitemid 36279231)
293. Lake AC, Sun Y, Li JL, et al. (2005) Expression, regulation, and triglyceride hydrolase activity of adiponutrin family members. J Lipid Res 46, 2477-2487. (Pubitemid 41532536)
294. Johansson LE, Lindblad U, Larsson CA, et al. (2008) Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity. Eur J Endocrinol 159, 577-583.
295. Basantani MK, Sitnick MT, Cai L, et al. (2011) Pnpla3/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 52, 318-329.
296. Brasaemle DL (2007) The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 48, 2547-2559. (Pubitemid 350272839)
297. Brasaemle DL, Subramanian V, Garcia A, et al. (2009) Peri-lipin A and the control of triacylglycerol metabolism. Mol Cell Biochem 326, 15-21.
298. Robenek H, Robenek MJ, Buers I, et al. (2005) Lipid droplets gain PAT family proteins by interaction with specialized plasma membrane domains. J Biol Chem 280, 26330-26338. (Pubitemid 41022231)
299. Robenek H, Robenek MJ & Troyer D (2005) PAT family proteins pervade lipid droplet cores. J Lipid Res 46, 1331-1338. (Pubitemid 43109848)
300. Londos C, Brasaemle DL, Schultz CJ, et al. (1999) Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol 10, 51-58. (Pubitemid 129505538)
301. Martínez-Botas J, Anderson JB, Tessier D, et al. (2000) Absence of perilipin results in leanness and reverses obesity in Lepr (db/db) mice. Nat Genet 26, 474-479.
302. Brasaemle DL, Rubin B, Harten IA, et al. (2000) Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 275, 38486-38493. (Pubitemid 32009175)
303. Kovsan J, Ben-Romano R, Souza SC, et al. (2007) Regulation of adipocyte lipolysis by degradation of the perilipin protein: nelfinavir enhances lysosome-mediated perilipin proteolysis. J Biol Chem 282, 21704-21711. (Pubitemid 47195753)
304. Miyoshi H, Perfield JWII, Souza SC, et al. (2007) Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes. J Biol Chem 282, 996-1002. (Pubitemid 47076543)
305. Miyoshi H, Souza SC, Zhang HH, et al. (2006) Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation- dependent and-independent mechanisms. J Biol Chem 281, 15837-15844. (Pubitemid 43848474)
306. Miyoshi H, Souza SC, Endo M, et al. (2010) Perilipin over-expression in mice protects against diet-induced obesity. J Lipid Res 51, 975-982.
307. McDonough PM, Maciejewski-Lenoir D, Hartig SM, et al. (2013) Differential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysis. PLOS ONE 8, e55511.
308. Yang X, Heckmann BL, Zhang X, et al. (2013) Distinct mechanisms regulate ATGL-mediated adipocyte lipolysis by lipid droplet coat proteins. Mol Endocrinol 27, 116-126.
309. Skinner JR, Harris LA, Shew TM, et al. (2013) Perilipin 1 moves between the fat droplet and the endoplasmic reticulum. Adipocyte 2, 80-86.
310. Takahashi Y, Shinoda A, Furuya N, et al. (2013) Perilipin-mediated lipid droplet formation in adipocytes promotes sterol regulatory element-binding protein-1 processing and triacylglyceride accumulation. PLOS ONE 8, e64605.
311. Beller M, Sztalryd C, Southall N, et al. (2008) COPI complex is a regulator of lipid homeostasis. PLoS Biol 6, e292.
312. Guo Y, Walther TC, Rao M, et al. (2008) Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 453, 657-661. (Pubitemid 351769298)
313. Takashima K, Saitoh A, Hirose S, et al. (2011) GBF1-Arf-COPI-ArfGAP- mediated Golgi-to-ER transport involved in regulation of lipid homeostasis. Cell Struct Funct 36, 223-235.
314. Zhou Z, Yon Toh S, Chen Z, et al. (2003) Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 35, 49-56. (Pubitemid 37048595)
315. Li JZ, Ye J, Xue B, et al. (2007) Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes 56, 2523-2532. (Pubitemid 47523259)
316. Qi J, Gong J, Zhao T, et al. (2008) Downregulation of AMP-Activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBO J 27, 1537-1548. (Pubitemid 351794037)
317. Ye J, Li JZ, Liu Y, et al. (2009) Cideb, an ER-And lipid droplet-Associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab 9, 177-190.
318. Tiwari S, Siddiqi S & Siddiqi SA (2013) Cideb protein is required for the biogenesis of very low density lipoprotein (VLDL) transport vesicle. J Biol Chem 288, 5157-5165.
319. Nordstrom EA, Ryden M, Backlund EC, et al. (2005) A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-A)-like effector A (CIDEA) in adipo-cyte lipolysis and obesity. Diabetes 54, 1726-1734. (Pubitemid 40770763)
320. Pettersson AT, Laurencikiene J, Nordstrom EA, et al. (2008) Characterization of the human CIDEA promoter in fat cells. Int J Obes (Lond) 32, 1380-1387.
321. Christianson JL, Boutet E, Puri V, et al. (2010) Identification of the lipid droplet targeting domain of the Cidea protein. J Lipid Res 51, 3455-3462.
322. Puri V, Ranjit S, Konda S, et al. (2008) Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A 105, 7833-7838. (Pubitemid 351872724)
323. Laurencikiene J, Stenson BM, Arvidsson Nordstrom E, et al. (2008) Evidence for an important role of CIDEA in human cancer cachexia. Cancer Res 68, 9247-9254.
324. Magnusson B, Gummesson A, Glad CA, et al. (2008) Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism. Metabolism 57, 1307-1313.
325. Ranjit S, Boutet E, Gandhi P, et al. (2011) Regulation of fat specific protein 27 by isoproterenol and TNF-A to control lipolysis in murine adipocytes. J Lipid Res 52, 221-236.
326. Kim YJ, Cho SY, Yun CH, et al. (2008) Transcriptional activation of Cidec by PPARg2 in adipocyte. Biochem Biophys Res Commun 377, 297-302.
327. Gong J, Sun Z, Wu L, et al. (2011) Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites. J Cell Biol 195, 953-963.
328. Grahn TH, Zhang Y, Lee MJ, et al. (2013) FSP27andPLIN1inter-Action promotes the formation of large lipid droplets in human adipocytes. Biochem Biophys Res Commun 432, 296-301.
329. Nian Z, Sun Z, Yu L, et al. (2010) Fat-specific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation. J Biol Chem 285, 9604-9615.
330. Barneda D, Frontini A, Cinti S, et al. (2013) Dynamic changes in lipid droplet-Associated proteins in the "browning" of white adipose tissues. Biochim Biophys Acta 1831, 924-933.
331. Muller G, Wied S, Walz N, et al. (2008) Translocation of gly-cosylphosphatidylinositol-Anchored proteins from plasma membrane microdomains to lipid droplets in rat adipocytes is induced by palmitate, H2O2, and the sulfonylurea drug glimepiride. Mol Pharmacol 73, 1513-1529. (Pubitemid 351574841)
332. Muller G, Jung C, Wied S, et al. (2009) Induced translocation of glycosylphosphatidylinositol-Anchored proteins from lipid droplets to adiposomes in rat adipocytes. Br J Pharmacol 158, 749-770.
333. Muller G (2011) Control of lipid storage and cell size between adipocytes by vesicle-Associated glycosylphospha-tidylinositol-Anchored proteins. Arch Physiol Biochem 117, 23-43.
334. Adeyo O, Goulbourne CN, Bensadoun A, et al. (2012) Glycosylphosphatidylinositol-Anchored high-density lipo-protein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins. J Intern Med 272, 528-540.
335. Peinado JR, Pardo M, de la Rosa O, et al. (2012) Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity. Proteo-mics 12, 607-620.
336. Malagon MM, Cruz D, Vazquez-Martinez R, et al. (2005) Analysis of Rab18 and a new golgin in the secretory pathway. Ann N Y Acad Sci 1040, 137-139. (Pubitemid 40979769)
337. Pulido MR, Diaz-Ruiz A, Jimenez-Gomez Y, et al. (2011) Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity. PLoS ONE 6, e22931.
338. Pulido MR, Rabanal-Ruiz Y, Almabouada F, et al. (2013) Nutritional, hormonal, and depot-dependent regulation of the expression of the small GTPase Rab18 in rodent adipose tissue. J Mol Endocrinol 50, 19-29.
339. Frühbeck G (2005) Obesity: aquaporin enters the picture. Nature 438, 436-437. (Pubitemid 41742005)
340. Frühbeck G, Catalán V, Gómez-Ambrosi J, et al. (2006) Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. Trends Pharmacol Sci 27, 345-347. (Pubitemid 43963182)
341. Walker CG, Holness MJ, Gibbons GF, et al. (2007) Fasting-induced increases in aquaporin 7 and adipose triglyceride lipase mRNA expression in adipose tissue are attenuated by peroxisome proliferator-Activated receptor a deficiency. Int J Obes (Lond) 31, 1165-1171. (Pubitemid 46987765)
342. Hara-Chikuma M, Sohara E, Rai T, et al. (2005) Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem 280, 15493-15496. (Pubitemid 40616663)
343. Hibuse T, Maeda N, Nagasawa A, et al. (2006) Aquaporins and glycerol metabolism. Biochim Biophys Acta 1758, 1004-1011. (Pubitemid 44373851)
344. Rodríguez A, Catalán V, Gómez-Ambrosi J, et al. (2011) Insulin-And leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J Clin Endocrinol Metab 96, E586-E597.
345. Frühbeck G, López M & Diéguez C (2007) Role of caveolins in body weight and insulin resistance regulation. Trends Endocrinol Metab 18, 177-182. (Pubitemid 46962299)
346. Trigatti BL, Anderson RG & Gerber GE (1999) Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun 255, 34-39. (Pubitemid 29292060)
347. Meshulam T, Simard JR, Wharton J, et al. (2006) Role of caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry (Mosc) 45, 2882-2893. (Pubitemid 43334537)
348. Meshulam T, Breen MR, Liu L, et al. (2011) Caveolins/caveolae protect adipocytes from fatty acid-mediated lipotoxicity. J Lipid Res 52, 1526-1532.
349. Cohen AW, Razani B, Schubert W, et al. (2004) Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 53, 1261-1270. (Pubitemid 38569012)
350. Covey SD, Brunet RH, Gandhi SG, et al. (2007) Cholesterol depletion inhibits fatty acid uptake without affecting CD36 or caveolin-1 distribution in adipocytes. Biochem Biophys Res Commun 355, 67-71. (Pubitemid 46273367)
351. Cohen AW, Razani B, Wang XB, et al. (2003) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285, C222-C235. (Pubitemid 36736354)
352. Ring A, Le Lay S, Pohl J, et al. (2006) Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. Biochim Biophys Acta 1761, 416-423. (Pubitemid 43776458)
353. Zhou D, Samovski D, Okunade AL, et al. (2012) CD36 level and trafficking are determinants of lipolysis in adipocytes. FASEB J 26, 4733-4742.
354. Vroegrijk IO, van Klinken JB, van Diepen JA, et al. (2013) CD36 is important for adipocyte recruitment and affects lipolysis. Obesity (Silver Spring) 21, 2037-2045.
355. Scheja L, Makowski L, Uysal KT, et al. (1999) Altered insulin secretion associated with reduced lipolytic efficiency in aP2 -/- mice. Diabetes 48, 1987-1994. (Pubitemid 29458361)
356. Lan H, Cheng CC, Kowalski TJ, et al. (2011) Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity. J Lipid Res 52, 646-656.
357. Wei S, Zan L, Wang H, et al. (2013) Adenovirus-mediated interference of FABP4 regulates mRNA expression of ADIPOQ, LEP and LEPR in bovine adipocytes. Genet Mol Res 12, 494-505.
358. Wu Q, Ortegon AM, Tsang B, et al. (2006) FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 26, 3455-3467.
359. Richards MR, Harp JD, Ory DS, et al. (2006) Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes. J Lipid Res 47, 665-672. (Pubitemid 43345607)
360. Liu Q, Gauthier MS, Sun L, et al. (2010) Activation of AMP-Activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio. FASEB J 24, 4229-4239.
361. Lenz LS, Marx J, Chamulitrat W, et al. (2011) Adipocyte-specific inactivation of acyl-CoA synthetase fatty acid transport protein 4 (Fatp4) in mice causes adipose hypertrophy and alterations in metabolism of complex lipids under high fat diet. J Biol Chem 286, 35578-35587.
362. Phillips CM, Goumidi L, Bertrais S, et al. (2010) Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. J Lipid Res 51, 1793-1800.
363. Rodríguez A, Catalán V, Gómez-Ambrosi J, et al. (2007) Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr Pharm Des 13, 2169-2175. (Pubitemid 47074048)
364. Tchkonia T, Thomou T, Zhu Y, et al. (2013) Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 17, 644-656.
365. Lafontan M & Berlan M (2003) Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 24, 276-283. (Pubitemid 36725002)
366. Caesar R, Manieri M, Kelder T, et al. (2010) A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences. PLoS ONE 5, e11525.
367. Martin ML & Jensen MD (1991) Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 88, 609-613.
368. Nielsen S, Guo Z, Johnson CM, et al. (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113, 1582-1588. (Pubitemid 39071681)
369. Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11, 11-18.
370. Arner P (1995) Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 27, 435-438.
371. Hoffstedt J, Arner P, Hellers G, et al. (1997) Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res 38, 795-804. (Pubitemid 27194930)
372. Zierath JR, Livingston JN, Thorne A, et al. (1998) Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41, 1343-1354. (Pubitemid 28488763)
373. Bolinder J, Kager L, Ostman J, et al. (1983) Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32, 117-123. (Pubitemid 13180343)
374. Rebuffe-Scrive M, Lonnroth P, Marin P, et al. (1987) Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes 11, 347-355. (Pubitemid 17138411)
375. Pedersen SB, Kristensen K, Hermann PA, et al. (2004) Estrogen controls lipolysis by up-regulating a2A-Adrenergic receptors directly in human adipose tissue through the estrogen receptor a. Implications for the female fat distribution. J Clin Endocrinol Metab 89, 1869-1878. (Pubitemid 38507947)
376. Frühbeck G & Gómez-Ambrosi J (2002) Depot-specific differences in the lipolytic effect of leptin on isolated white adipocytes. Med Sci Monit 8, BR47-BR55. (Pubitemid 34218450)
377. Dessi-Fulgheri P, Sarzani R & Rappelli A (2003) Role of the natriuretic peptide system in lipogenesis/lipolysis. Nutr Metab Cardiovasc Dis 13, 244-249. (Pubitemid 38569441)
378. Dicker A, Astrom G, Wahlen K, et al. (2009) Primary differences in lipolysis between human omental and subcutaneous adipose tissue observed using in vitro differentiated adipocytes. Horm Metab Res 41, 350-355.
379. Karelis AD (2011) To be obese-does it matter if you are metabolically healthy? Nat Rev Endocrinol 7, 699-700.
380. de Gusmao Correia ML (2013) Is 'metabolically healthy' obesity a benign condition? J Hypertens 31, 39-41.
381. Ahima RS & Lazar MA (2013) Physiology. The health risk of obesity-better metrics imperative. Science 341, 856-858.
382. Czaja MJ (2011) Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology 140, 1895-1908.
383. Singh R & Cuervo AM (2011) Autophagy in the cellular energetic balance. Cell Metab 13, 495-504.
384. Singh R (2012) Autophagy in the control of food intake. Adipocyte 1, 75-79.
385. Russell RC, Tian Y, Yuan H, et al. (2013) ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 15, 741-750.
386. Kanazawa T, Taneike I, Akaishi R, et al. (2004) Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes. J Biol Chem 279, 8452-8459. (Pubitemid 38294738)
387. Pattingre S, Espert L, Biard-Piechaczyk M, et al. (2008) Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90, 313-323. (Pubitemid 351181247)
388. Moscat J & Diaz-Meco MT (2012) Feedback on fat: p62-mTORC1-Autophagy connections. Cell 147, 724-727.
389. Singh R, Xiang Y, Wang Y, et al. (2009) Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 119, 3329-3339.
390. Zhang Y, Goldman S, Baerga R, et al. (2009) Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc Natl Acad Sci U S A 106, 19860-19865.
391. Wu J, Bostrom P, Sparks LM, et al. (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366-376.
392. Martinez-Lopez N, Athonvarangkul D, Sahu S, et al. (2013) Autophagy in Myf5 + progenitors regulates energy and glucose homeostasis through control of brown fat and skeletal muscle development. EMBO Rep 14, 795-803.
393. Kovsan J, Blüher M, Tarnovscki T, et al. (2011) Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab 96, E268-E277.
394. Nuñez CE, Rodrigues VS, Gomes FS, et al. (2013) Defective regulation of adipose tissue autophagy in obesity. Int J Obes (Lond) 37, 1473-1480.
395. Ost A, Svensson K, Ruishalme I, et al. (2010) Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med 16, 235-246.
396. Kawakami M, Murase T, Ogawa H, et al. (1987) Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem 101, 331-338. (Pubitemid 17004304)
397. López M, Lage R, Saha AK, et al. (2008) Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 7, 389-399. (Pubitemid 351618114)
398. Murano I, Rutkowski JM, Wang QA, et al. (2013) Time course of histomorphological changes in adipose tissue upon acute lipoatrophy. Nutr Metab Cardiovasc Dis 23, 723-731.
399. Giordano A, Murano I, Mondini E, et al. (2013) Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res 54, 2423-2436.
400. Hotamisligil GS, Shargill NS & Spiegelman BM (1993) Adipose expression of tumor necrosis factor-91.
401. Mauriege P, Despres JP, Prud'homme D, et al. (1991) Regional variation in adipose tissue lipolysis in lean and obese men. J Lipid Res 32, 1625-1633.
402. Jocken JW, Goossens GH, van Hees AM, et al. (2008) Effect of b-Adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men. Diabetologia 51, 320-327.
403. Dahlman I & Arner P (2007) Obesity and polymorphisms in genes regulating human adipose tissue. Int J Obes (Lond) 31, 1629-1641. (Pubitemid 350023156)
404. Terra SG, McGorray SP, Wu R, et al. (2005) Association between b-Adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int J Obes (Lond) 29, 746-754. (Pubitemid 40897009)
405. Hoffstedt J, Iliadou A, Pedersen NL, et al. (2001) The effect of the beta2 adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol 133, 708-712. (Pubitemid 32642876)
406. Eriksson P, Dahlman I, Ryden M, et al. (2004) Relationship between b2-Adrenoceptor gene haplotypes and adipocyte lipolysis in women. Int J Obes Relat Metab Disord 28, 185-190. (Pubitemid 38223498)
407. Ryden M, Hoffstedt J, Eriksson P, et al. (2001) The Arg 389 Gly b1-Adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obes Relat Metab Disord 25, 1599-1603. (Pubitemid 33052066)
408. Tafel J, Branscheid I, Skwarna B, et al. (2004) Variants in the human b1-, b2-, and b3-Adrenergic receptor genes are not associated with morbid obesity in children and adolescents. Diabetes Obes Metab 6, 452-455. (Pubitemid 39409796)
409. Li LS, Lönnqvist F, Luthman H, et al. (1996) Phenotypic characterization of the Trp64Arg polymorphism in the b3-Adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39, 857-860. (Pubitemid 26228117)
410. Buettner R, Schaffler A, Arndt H, et al. (1998) The Trp64Arg polymorphism of the b3-Adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 83, 2892-2897. (Pubitemid 28493794)
411. Snitker S, Odeleye OE, Hellmer J, et al. (1997) No effect of the Trp64Arg b3-Adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue. Diabetologia 40, 838-842. (Pubitemid 27306963)
412. Jocken JW, Goossens GH, Boon H, et al. (2013) Insulinmediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance. Diabetologia 56, 2255-2265.
413. Mairal A, Langin D, Arner P, et al. (2006) Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity. Diabetologia 49, 1629-1636. (Pubitemid 43848100)
414. Large V, Reynisdottir S, Langin D, et al. (1999) Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 40, 2059-2066.
415. Tinahones FJ, Garrido-Sanchez L, Miranda M, et al. (2010) Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg 20, 1559-1567.
416. Gandotra S, Le Dour C, Bottomley W, et al. (2011) Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med 364, 740-748.
417. Gandotra S, Lim K, Girousse A, et al. (2011) Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5). J Biol Chem 286, 34998-35006.
418. Cusano NE, Kiel DP, Demissie S, et al. (2012) Apolymorphism in a gene encoding perilipin 4 is associated with height but not with bone measures in individuals from the Framingham Osteoporosis Study. Calcif Tissue Int 90, 96-107.
419. Magné J, Aminoff A, Sundelin JP, et al. (2013) The minor allele of the missense polymorphism Ser251Pro in perilipin 2 (PLIN2) disrupts an a-helix, affects lipolysis, and is associated with reduced plasma triglyceride concentration in humans. FASEB J 27, 3090-3099.
420. Lass A, Zimmermann R, Haemmerle G, et al. (2006) Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome. Cell Metab 3, 309-319.
421. Yamaguchi T & Osumi T (2009) Chanarin-Dorfman syndrome: deficiency in CGI-58, a lipid droplet-bound coactivator of lipase. Biochim Biophys Acta 1791, 519-523.
422. Bezaire V, Mairal A, Ribet C, et al. (2009) Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysisinhMADS adipocytes. J BiolChem 284, 18282-18291.
423. Rodríguez A, Catalán V, Gómez-Ambrosi J, et al. (2011) Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control. Cell Cycle 10, 1548-1556.
424. Kishida K, Kuriyama H, Funahashi T, et al. (2000) Aquaporin adipose, a putative glycerol channel in adipo-cytes. J Biol Chem 275, 20896-20902. (Pubitemid 30457685)
425. Yasui H, Kubota M, Iguchi K, et al. (2008) Membrane trafficking of aquaporin 3 induced by epinephrine. Bio-chem Biophys Res Commun 373, 613-617.
426. Rodríguez A, Catalán V, Gómez-Ambrosi J, et al. (2006) Role of aquaporin-7 in the pathophysiological control of fat accumulation in mice. FEBS Lett 580, 4771-4776. (Pubitemid 44286845)
427. Catalán V, Gómez-Ambrosi J, Pastor C, et al. (2008) Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg 18, 695-701.
428. Lafontan M (2012) Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physiol 302, C327-C359.
429. Zhang Y, Proenca R, Maffei M, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. (Pubitemid 24365442)
430. Zierler KA, Jaeger D, Pollak NM, et al. (2013) Functional cardiac lipolysis in mice critically depends on comparative gene identification-58. J Biol Chem 288, 9892-9904.
431. Harant I, Beauville M, Crampes F, et al. (1994) Response of fat cells to growth hormone (GH): effect of long term treatment with recombinant human GH in GH-deficient adults. J Clin Endocrinol Metab 78, 1392-1395. (Pubitemid 24181010)
432. Miegueu P, Pierre DS, Broglio F, et al. (2011) Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 112, 704-714.
433. Granata R, Gallo D, Luque RM, et al. (2012) Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 26, 3393-3411.
434. Hauner H, Petruschke T, Russ M, et al. (1995) Effects of tumour necrosis factor a (TNF a) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38, 764-771.
435. Path G, Bornstein SR, Gurniak M, et al. (2001) Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by b-Adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab 86, 2281-2288. (Pubitemid 32472953)
436. Grisouard J, Bouillet E, Timper K, et al. (2012) Both inflammatory and classical lipolytic pathways are involved in lipopolysaccharide-induced lipolysis in human adipo-cytes. Innate Immun 18, 25-34.